Angiotensin-converting enzyme inhibitor suppresses tubular expression of platelet-derived growth factor and attenuates progression of tubulo-interstitial fibrosis in a nephrotic mouse model.
Mizuno
S
S
Mizuno-Horikawa
Y
Y
Okamoto
M
M
Kurosawa
T
T
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology*; D000818:Animals; D004656:Enalapril / Q000494:pharmacology; D005353:Fibronectins / Q000378:metabolism; D007684:Kidney Tubules / Q000187:drug effects / Q000378:metabolism*; D051379:Mice; D008815:Mice, Inbred Strains; D009395:Nephritis, Interstitial / Q000188:drug therapy* / Q000473:pathology; D009401:Nephrosis / Q000235:genetics / Q000473:pathology*; D010982:Platelet-Derived Growth Factor / Q000096:biosynthesis*
D000806:Angiotensin-Converting Enzyme Inhibitors; D005353:Fibronectins; D010982:Platelet-Derived Growth Factor; D004656:Enalapril